What is HYPD's relative strength rating?

HYPD ranks at the 85th percentile over 1 month, 20th percentile over 3 months, 43th percentile over 6 months, 15th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is HYPD in?

HYPD is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.

Is HYPD in a leading sector?

Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). HYPD benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.

How volatile is HYPD?

HYPD currently shows a 20-day average daily range (ADR%) of 7.8%, a 90-day beta versus the S&P 500 of 2.56. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does HYPD have a seasonal pattern?

TickerStance computes HYPD's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what HYPD has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did HYPD last report earnings?

HYPD most recently filed a 10-Q covering FY26 Q2 with the SEC on 2026-08-13. TickerStance sources earnings data from SEC EDGAR XBRL submissions and updates the fundamentals panel daily. The Pro dossier shows eight quarters of EPS and revenue trend, operating margin history, and a composite earnings-quality rank.

Hyperion DeFi, Inc. Common Stock (HYPD) · RS 43

TODAY'S READ · AS OF 2026-08-21

As of 2026-08-21, Hyperion DeFi, Inc. Common Stock (HYPD) has a 3-month relative strength percentile of 20 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 40. The current market Stance is 49.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 7.8%, relative volume 2.38×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

RS methodology →

Market-wide RS; lit = leaderboard

Lenses lit

3 month20pctile

6 month43pctile

1 year15pctile

Classic17IBD pctile

LDR9leadership

0 of 5 lenses lit · avg RS pctile 21

✓ADR%7.8%✓A/DA✓RVOL2.38×!$ Vol$1M

Market backdrop

49.9Neutral

Trend30% weight46.6 Breadth30% weight58.1 Leadership20% weight36.3 Macro20% weight56.5 Full stance breakdown →

§ Seasonality

10y · since 2025

Best monthSep on averageavg +57.05% · 100% win · n 1

Worst monthOct on averageavg -32.36% · 0% win · n 1

HYPD monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	HYPD Jan avg: -1.12% median: -1.12% win: 0% σ: 0.00% n: 1 2025-07-07 → 2026-07-31	HYPD Feb avg: -19.89% median: -19.89% win: 0% σ: 0.00% n: 1 2025-07-07 → 2026-07-31	HYPD Mar avg: 22.34% median: 22.34% win: 100% σ: 0.00% n: 1 2025-07-07 → 2026-07-31	HYPD Apr avg: 16.96% median: 16.96% win: 100% σ: 0.00% n: 1 2025-07-07 → 2026-07-31	HYPD May avg: -13.26% median: -13.26% win: 0% σ: 0.00% n: 1 2025-07-07 → 2026-07-31	HYPD Jun avg: -10.29% median: -10.29% win: 0% σ: 0.00% n: 1 2025-07-07 → 2026-07-31	HYPD Jul avg: -29.20% median: -29.20% win: 0% σ: 18.78% n: 2 2025-07-07 → 2026-07-31	HYPD Aug avg: -26.15% median: -26.15% win: 0% σ: 0.00% n: 1 2025-07-07 → 2026-07-31 (current)	HYPD Sep avg: 57.05% median: 57.05% win: 100% σ: 0.00% n: 1 2025-07-07 → 2026-07-31	HYPD Oct avg: -32.36% median: -32.36% win: 0% σ: 0.00% n: 1 2025-07-07 → 2026-07-31	HYPD Nov avg: -30.40% median: -30.40% win: 0% σ: 0.00% n: 1 2025-07-07 → 2026-07-31	HYPD Dec avg: -21.06% median: -21.06% win: 0% σ: 0.00% n: 1 2025-07-07 → 2026-07-31

Evidence · 1 of 3

Receipts behind the read

1 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

1m

85

3m

20

6m

43

1y

15

LDR

—

StageWeinstein stage analysis

Stage 4 · Decline

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

A/D ratingaccumulation / distribution

AAccum

RVOL todayvs 50d avg

2.38×

U/D ratiolast 50 sessions

1.78

Breakout volbreakout day vs 50d avg

+82%

50d avg $ volumeliquidity proxy

$1.4M

Risk profile

How much does it move?

Daily range, ATR, beta, and the math for a 1-ADR stop.

ADR% (20d)avg daily range

7.8%Elevated

ATR(14)14-day EMA

$0.25

ATR%ATR as % of close

7.82%

Beta vs SPY90d rolling

2.56

1-ADR stoprisk from close $3.18

$2.93−7.8%

Fundamentals · HYPD

Does the business back the chart?

SEC EDGAR · last filing 10-Q · FY26 Q2 · period end 2026-06-30

61

Fundamentals Growth Rank

How does growth rank vs. the universe?

vs. 4,476 ranked stocks · Sector rank 63

View fundamental leadership map

Average

Earnings

Is earnings accelerating?

Diluted EPS, last 8 quarters. Positive EPS uses YoY change.

Turned profitable

−$0.11—

24 Q3

−$59.26—

24 Q4

−$1.59—

25 Q1

−$2.50—

25 Q2

$0.05Profit

25 Q3

−$5.36+91%

25 Q4

$0.26Profit

26 Q1

$0.92Profit

26 Q2

Latest Q EPS$0.92Turned profitable Profit

Revenue

Is revenue confirming?

YoY sales growth, last 8 quarters. Sales must back the earnings story.

—

24 Q3

+2245%

24 Q4

+195%

25 Q1

−100%

25 Q2

+18516%

25 Q3

+1666%

25 Q4

+1559%

26 Q1

—

26 Q2

Latest Q YoY—

Quality

Are margins expanding?

Operating margin unavailable

No comparable operating-income series in SEC facts.

TTM op margin-

Float

Share count: tailwind or headwind?

YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.

Dilutive · +172.9% YoY

0.09B

24 Q3

0.00B

24 Q4

0.00B

25 Q1

0.01B

25 Q2

0.01B

25 Q3

0.01B

25 Q4

0.02B

26 Q1

0.02B

26 Q2

YoY common shares+172.9%

Reported figures from SEC filings. No analyst estimates or forward guidance.

Evidence · 2 of 3

Sector context

Healthcare · 82th pctile in sector

Top peers · Healthcare

Who else is leading?

ELOX
99RS 3m
FBRX
99RS 3m
MRNA
99RS 3m
HYPD
20RS 3m · you

Sector vs market

Healthcare · 3 of 11

Energy100

Technology91

Healthcare82

Materials73

Industrials64

Financials55

Real Estate45

Consumer Staples36

RS pctileLagLead

PEERS · Pharmaceutical Products

Same industry, closest relative strength

4 peers · by RS6M

INCRIntercure Ltd. Ordinary Shares43 ANIPANI Pharmaceuticals, Inc.43 GILDGilead Sciences Inc43 BLRXBioLineRX Ltd43

Public attention · HYPD

Is the crowd watching?

49/ 100 · vs its own 90-day norm▼ 33 vs 7dOverlooked

Weak relative strength and quiet attention. Little to read here either way.

Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.

News

Company snapshot

SectorHealthcare

IndustryPharmaceutical Products

SIC2834

Float14.5Mshares

Shares out15.2Mshares

Market cap$48.2MNano Cap

FAQ

Frequently asked questions

What is HYPD's relative strength rating?: HYPD ranks at the 85th percentile over 1 month, 20th percentile over 3 months, 43th percentile over 6 months, 15th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is HYPD in?: HYPD is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.
Is HYPD in a leading sector?: Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). HYPD benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
How volatile is HYPD?: HYPD currently shows a 20-day average daily range (ADR%) of 7.8%, a 90-day beta versus the S&P 500 of 2.56. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does HYPD have a seasonal pattern?: TickerStance computes HYPD's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what HYPD has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.
When did HYPD last report earnings?: HYPD most recently filed a 10-Q covering FY26 Q2 with the SEC on 2026-08-13. TickerStance sources earnings data from SEC EDGAR XBRL submissions and updates the fundamentals panel daily. The Pro dossier shows eight quarters of EPS and revenue trend, operating margin history, and a composite earnings-quality rank.

Hyperion DeFi, Inc. Common Stock (HYPD) — Stance & relative strength

Lenses lit

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Does the business back the chart?

Is earnings accelerating?

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions

Hyperion DeFi, Inc. Common Stock (HYPD) — Stance & relative strength

Lenses lit

Market backdrop

§ Seasonality

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Does the business back the chart?

Is earnings accelerating?

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions

§ Seasonality

Hyperion DeFi, Inc. Common Stock (HYPD) — Stance & relative strength

HYPD is not confirmed as a leader. 20 is not yet a leadership-grade RS read, Market Stance is 49.9

Lenses lit

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Does the business back the chart?

Is earnings accelerating?

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions

Hyperion DeFi, Inc. Common Stock (HYPD) — Stance & relative strength

HYPD is not confirmed as a leader. 20 is not yet a leadership-grade RS read, Market Stance is 49.9

Lenses lit

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Does the business back the chart?

Is earnings accelerating?

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions